ask="4.60"
ask_size="500"
average_daily_volume="139226"
bid="3.84"
bid_size="100"
book_value="2.54"
change="+0.19"
change_from_200_day_moving_average="-1.25"
change_from_50_day_moving_average="0.32"
change_from_52_week_high="-7.09"
change_From_52_week_low="0.74"
change_in_percent="+4.41%"
close="4.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="-74.76M"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.17"
ex_dividend_date="N/A"
float_shares="23413000"
high="4.58"
high_52_weeks="11.59"
last_trade_date="2/1/2017"
last_trade_price="4.50"
last_trade_size="568"
last_trade_time="4:00pm"
low="4.31"
low_52_weeks="3.76"
market_capitalization="318.53M"
moving_average_200_day="5.75"
moving_average_50_day="4.18"
name="Adaptimmune Therapeutics plc"
notes="N/A"
one_year_target_price="15.20"
open="4.31"
pe_ratio="N/A"
peg_ratio="0.30"
percent_change_from_200_day_moving_average="-21.77%"
percent_change_from_50_day_moving_average="+7.69%"
percent_change_from_52_week_high="-61.17%"
percent_change_from_52_week_low="+19.68%"
previous_close="4.31"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.69"
price_per_sales="32.03"
revenue="9.52M"
shares_outstanding="70785000"
short_ratio="2.34"
stock_exchange="NMS"
symbol="ADAP"
volume="110786"
weeks_range_52="3.76 - 11.59"
